Clinical Trials Browser

Phase 2/3 × Liver Cirrhosis × Gastrointestinal × Clear all

NCT00151671 2012-02-27

IMPACT

Phase 2/3 Terminated

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms